chr1-248406602-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_030904.2(OR2T1):āc.455C>Gā(p.Ser152Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00117 in 1,614,142 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_030904.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR2T1 | NM_030904.2 | c.455C>G | p.Ser152Cys | missense_variant | 2/2 | ENST00000642005.1 | NP_112166.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR2T1 | ENST00000642005.1 | c.455C>G | p.Ser152Cys | missense_variant | 2/2 | NM_030904.2 | ENSP00000493164.1 |
Frequencies
GnomAD3 genomes AF: 0.000756 AC: 115AN: 152180Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000788 AC: 198AN: 251138Hom.: 1 AF XY: 0.000840 AC XY: 114AN XY: 135716
GnomAD4 exome AF: 0.00122 AC: 1781AN: 1461844Hom.: 4 Cov.: 36 AF XY: 0.00116 AC XY: 843AN XY: 727218
GnomAD4 genome AF: 0.000755 AC: 115AN: 152298Hom.: 0 Cov.: 32 AF XY: 0.000806 AC XY: 60AN XY: 74460
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 10, 2024 | The c.608C>G (p.S203C) alteration is located in exon 1 (coding exon 1) of the OR2T1 gene. This alteration results from a C to G substitution at nucleotide position 608, causing the serine (S) at amino acid position 203 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at